Literature DB >> 18301023

Factors associated with follow-up eye examinations among persons with diabetes.

Jinaan B Saadine1, Donald S Fong, Janis Yao.   

Abstract

OBJECTIVE: The authors investigated the process of diabetes eye care by assessing follow-up eye examinations in patients with diagnosed diabetes in a managed care organization.
METHODS: The authors randomly identified 5,000 diabetic patients from the Kaiser Permanente Southern California diabetes case identification database. A total of 2,412 patients received an eye examination during the enrollment period. The medical records of these patients then were reviewed to determine the interval of the next eye examination. The authors investigated characteristics of patients who had a follow-up examination within 1 year and >1 year.
RESULTS: Although every diabetic patient is sent an annual reminder to get an eye examination, only 27.6% of patients were re-examined within 1 year. One third of patients with diabetes did not see an ophthalmologist or optometrist in the next 2 years even though a substantial number had already been diagnosed with retinopathy. Patients who were older, had a longer duration of diabetes, and used insulin were more likely to have a follow-up examination within 1 year. Neither levels of glycosylated hemoglobin or serum cholesterol nor race/ethnicity were associated with likelihood of getting a repeat examination. Patients who had slightly worse visual acuity and retinopathy level were more likely to have an examination within 1 year.
CONCLUSION: The current report assesses the process of eye care by investigating the frequency of follow-up examination in patients with diabetes mellitus. Patients who were older, with longer duration of diabetes, with poorer vision and more severe retinopathy were more likely to have a follow-up examination within 1 year. Glycemic control and race/ethnicity were not associated with follow-up within 1 year. Additional studies are needed to further understand the barriers to receiving a follow-up eye examination among people with diabetes.

Entities:  

Mesh:

Year:  2008        PMID: 18301023     DOI: 10.1097/IAE.0b013e318115169a

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  20 in total

1.  Income-related inequalities in visual impairment and eye screening services in patients with type 2 diabetes.

Authors:  Jongnam Hwang; Christopher Rudnisky; Sarah Bowen; Jeffrey A Johnson
Journal:  J Public Health (Oxf)       Date:  2016-12-02       Impact factor: 2.341

2.  Decomposing socioeconomic inequalities in the use of preventive eye screening services among individuals with diabetes in Korea.

Authors:  Jongnam Hwang
Journal:  Int J Public Health       Date:  2016-03-16       Impact factor: 3.380

3.  Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage.

Authors:  Reinhard Angermann; Teresa Rauchegger; Yvonne Nowosielski; Marina Casazza; Angelika Bilgeri; Hanno Ulmer; Claus Zehetner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-07-09       Impact factor: 3.117

4.  Influence of comorbidities on the implementation of the fundus examination in patients with newly diagnosed type 2 diabetes.

Authors:  Taichi Kawamura; Izumi Sato; Hiroshi Tamura; Yoko M Nakao; Koji Kawakami
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

5.  Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti-Vascular Endothelial Growth Factor Injections.

Authors:  Anthony Obeid; Xinxiao Gao; Ferhina S Ali; Christopher M Aderman; Abtin Shahlaee; Murtaza K Adam; Sundeep K Kasi; Leslie Hyman; Allen C Ho; Jason Hsu
Journal:  JAMA Ophthalmol       Date:  2018-11-01       Impact factor: 7.389

6.  Use of electronic health records and administrative data for public health surveillance of eye health and vision-related conditions in the United States.

Authors:  Amanda F Elliott; Arthur Davidson; Flora Lum; Michael F Chiang; Jinan B Saaddine; Xinzhi Zhang; John E Crews; Chiu-Fang Chou
Journal:  Am J Ophthalmol       Date:  2012-12       Impact factor: 5.258

7.  A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy.

Authors:  April Y Maa; William J Feuer; C Quentin Davis; Ensa K Pillow; Tara D Brown; Rachel M Caywood; Joel E Chasan; Stephen R Fransen
Journal:  J Diabetes Complications       Date:  2015-12-09       Impact factor: 2.852

8.  Gaps in receipt of regular eye examinations among medicare beneficiaries diagnosed with diabetes or chronic eye diseases.

Authors:  Frank A Sloan; Arseniy P Yashkin; Yiqun Chen
Journal:  Ophthalmology       Date:  2014-09-07       Impact factor: 12.079

9.  Screening for diabetic retinopathy and nephropathy in patients with diabetes: a nationwide survey in Korea.

Authors:  Sang-Ho Byun; Seung Hyun Ma; Jae Kwan Jun; Kyu-Won Jung; Boyoung Park
Journal:  PLoS One       Date:  2013-05-08       Impact factor: 3.240

Review 10.  Interventions to increase attendance for diabetic retinopathy screening.

Authors:  John G Lawrenson; Ella Graham-Rowe; Fabiana Lorencatto; Jennifer Burr; Catey Bunce; Jillian J Francis; Patricia Aluko; Stephen Rice; Luke Vale; Tunde Peto; Justin Presseau; Noah Ivers; Jeremy M Grimshaw
Journal:  Cochrane Database Syst Rev       Date:  2018-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.